Literature DB >> 9085108

Neural conduction in the visual pathways in ocular hypertension and glaucoma.

V Parisi1.   

Abstract

BACKGROUND: The aim of our work was to evaluate neural conduction in visual pathways in subjects with ocular hypertension and glaucoma.
METHODS: We assessed simultaneous recordings of pattern electroretinograms (PERG) and visual evoked potentials (VEP) in 16 subjects with ocular hypertension (OHT), in 16 subjects with primary open-angle glaucoma (POAG) and in 15 age-matched controls. The visual stimuli were checkerboard patterns (the check edges subtend 15 min of visual arc; contrast 70%) reversed at the rate of 2 reversals/s.
RESULTS: In OHT and POAG patients we found PERG and VEP latencies significantly longer than in controls. The P50-N95 PERG amplitudes were significantly reduced in OHT and POAG eyes. VEP amplitudes were significantly reduced in POAG eyes, while in OHT they were similar to controls. The retinocortical time (RCT; difference between VEP P100 latency and PERG P50 latency) was longer in POAG patients than in controls; no differences between patients with OHT and controls were observed. Moreover, we observed that in POAG the longer RCT was inversely related to the PERG amplitude.
CONCLUSION: Our results suggest that involvement of the innermost retinal layers in POAG is accompanied by slowed neural conduction in the visual pathways.

Entities:  

Mesh:

Year:  1997        PMID: 9085108     DOI: 10.1007/bf00941720

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  44 in total

1.  Effect of short-term intraocular pressure elevation on the rabbit electroretinogram.

Authors:  J G Feghali; J C Jin; J V Odom
Journal:  Invest Ophthalmol Vis Sci       Date:  1991-07       Impact factor: 4.799

2.  Pattern-evoked potentials and optic nerve fiber loss in monocular laser-induced glaucoma.

Authors:  M A Johnson; B A Drum; H A Quigley; R M Sanchez; G R Dunkelberger
Journal:  Invest Ophthalmol Vis Sci       Date:  1989-05       Impact factor: 4.799

3.  The second harmonic of the electroretinogram to sinusoidal flicker: spatiotemporal properties and clinical application.

Authors:  V Porciatti; G Moretti; P Ciavarella; B Falsini
Journal:  Doc Ophthalmol       Date:  1993       Impact factor: 2.379

4.  Pattern ERG in the monkey after section of the optic nerve.

Authors:  L Maffei; A Fiorentini; S Bisti; H Holländer
Journal:  Exp Brain Res       Date:  1985       Impact factor: 1.972

5.  Visual evoked cortical potential to paracentral retinal stimulation in chronic glaucoma, ocular hypertension, and an age-matched group of normals.

Authors:  J W Howe; K W Mitchell
Journal:  Doc Ophthalmol       Date:  1986-06-16       Impact factor: 2.379

6.  Chronic human glaucoma causing selectively greater loss of large optic nerve fibers.

Authors:  H A Quigley; G R Dunkelberger; W R Green
Journal:  Ophthalmology       Date:  1988-03       Impact factor: 12.079

7.  Electroretinographic responses to alternating gratings in the cat.

Authors:  L Maffei; A Fiorentini
Journal:  Exp Brain Res       Date:  1982       Impact factor: 1.972

8.  Flash and pattern electroretinograms in normal and laser-induced glaucomatous primate eyes.

Authors:  M S Marx; S M Podos; I Bodis-Wollner; J R Howard-Williams; M J Siegel; C S Teitelbaum; E L Maclin; C Severin
Journal:  Invest Ophthalmol Vis Sci       Date:  1986-03       Impact factor: 4.799

9.  Simultaneous recording of pattern electroretinography and visual evoked potentials in multiple sclerosis. A method to separate demyelination from axonal damage to the optic nerve.

Authors:  G G Celesia; D Kaufman; S B Cone
Journal:  Arch Neurol       Date:  1986-12

10.  A 3-year follow-up study of ocular hypertension by pattern electroretinogram.

Authors:  M Arai; N Yoshimura; H Sakaue; E Chihara; Y Honda
Journal:  Ophthalmologica       Date:  1993       Impact factor: 3.250

View more
  10 in total

1.  Pattern electroretinogram association with spectral domain-OCT structural measurements in glaucoma.

Authors:  C Bowd; A Tafreshi; L M Zangwill; F A Medeiros; P A Sample; R N Weinreb
Journal:  Eye (Lond)       Date:  2010-12-24       Impact factor: 3.775

2.  Electrophysiological assessment of glaucomatous visual dysfunction during treatment with cytidine-5'-diphosphocholine (citicoline): a study of 8 years of follow-up.

Authors:  Vincenzo Parisi
Journal:  Doc Ophthalmol       Date:  2005-01       Impact factor: 2.379

3.  Treatment with citicoline eye drops enhances retinal function and neural conduction along the visual pathways in open angle glaucoma.

Authors:  Vincenzo Parisi; Marco Centofanti; Lucia Ziccardi; Lucia Tanga; Manuele Michelessi; Gloria Roberti; Gianluca Manni
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-05-26       Impact factor: 3.117

4.  Enhancement of Retinal Function and of Neural Conduction Along the Visual Pathway Induced by Treatment with Citicoline Eye Drops in Liposomal Formulation in Open Angle Glaucoma: A Pilot Electrofunctional Study.

Authors:  Vincenzo Parisi; Francesco Oddone; Gloria Roberti; Lucia Tanga; Carmela Carnevale; Lucia Ziccardi; Gianluca Manni
Journal:  Adv Ther       Date:  2019-02-21       Impact factor: 3.845

5.  The effects of glaucoma on the latency of the multifocal visual evoked potential.

Authors:  C Rodarte; D C Hood; E B Yang; T Grippo; V C Greenstein; J M Liebmann; R Ritch
Journal:  Br J Ophthalmol       Date:  2006-05-17       Impact factor: 4.638

6.  Impaired saccadic eye movement in diabetic patients: the relationship with visual pathways function.

Authors:  M Alessandrini; V Paris; E Bruno; P G Giacomini
Journal:  Doc Ophthalmol       Date:  1999       Impact factor: 2.379

7.  Color Doppler imaging and pattern visual evoked potential in normal tension glaucoma and hypertension glaucoma.

Authors:  Yisheng Zhong; Yingjun Min; Ying Jiang; Yu Cheng; Jiao Qin; Xi Shen
Journal:  Doc Ophthalmol       Date:  2009-09-12       Impact factor: 2.379

8.  The neuroprotective role of citicoline treatment in glaucoma - 6 months results of a prospective therapeutic trial.

Authors:  Iulia Chițu; Liliana-Mary Voinea; Sânziana Istrate; Alexandra Vrapciu; Radu Constantin Ciuluvică; Ruxandra Tudosescu
Journal:  Rom J Ophthalmol       Date:  2019 Jul-Sep

9.  XIAP gene therapy effects on retinal ganglion cell structure and function in a mouse model of glaucoma.

Authors:  Shagana Visuvanathan; Adam N Baker; Pamela S Lagali; Stuart G Coupland; Garfield Miller; William W Hauswirth; Catherine Tsilfidis
Journal:  Gene Ther       Date:  2021-08-06       Impact factor: 5.250

Review 10.  Citicoline and Retinal Ganglion Cells: Effects on Morphology and Function.

Authors:  Vincenzo Parisi; Francesco Oddone; Lucia Ziccardi; Gloria Roberti; Gianluca Coppola; Gianluca Manni
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.